Pleomorphic Xanthoastrocytoma
What's New
Last Posted: Mar 15, 2023
- Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma.
Zhang Hui, et al. Current oncology (Toronto, Ont.) 2023 0 (2) 2405-2416 - Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
Kim Hyunhee, et al. Laboratory investigation; a journal of technical methods and pathology 2023 0 (2) 160-171 - Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
Dal Col Pierre, et al. Journal of neuropathology and experimental neurology 2020 0 (9) 1011-1014 - Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.
Wang Yujiao, et al. Brain pathology (Zurich, Switzerland) 2021 0 (1) e13011 - [Anaplastic pleomorphic xanthoastrocytoma - single-center analysis of 42 patients].
Belyaev A Yu, et al. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2022 0 (2) 45-54 - Gene expression based profiling of pleomorphic xanthoastrocytoma highlights two prognostic subgroups.
Singh Jyotsna, et al. American journal of translational research 2022 0 (2) 1010-1023 - High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
Pratt Drew, et al. Acta neuropathologica 2022 0 (3) 403-414 - Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation.
Gandham Edmond Jonathan, et al. World neurosurgery 2022 5 - Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Vaubel Rachael, et al. Brain pathology (Zurich, Switzerland) 2020 7 - The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Phillips Joanna J, et al. Brain pathology (Zurich, Switzerland) 2019 1 (1) 85-96
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: